Performing the processes of validation, conditioning and elaboration of antineoplastic and biological treatments, maintaining the guidelines established in the Good Manufacturing Practices (GMP), is the objective pursued by the new ePASE system with which the pharmacy service has recently begun to work of the HUMT.
News
The Pharmacy service of HUMT implements a system that adds quality and safety in the antineoplastic and biological treatments
This module allows to control simultaneously which drug and how much is added to a preparation (parenteral mixture) by qualitative control (barcode readers and matrix date) and quantitative control (precision balance for gravimetric control).
Regarding its peculiarities, the ePASE allows monitoring in real time -by tele-validation- of all the steps that become the biological security booth, facilitating the control of the risk of occupational exposure of all professionals involved in the preparation of the medication.
In addition, the new system offers statistics (predefined or configurable) of high value for the continuous improvement of the quality of care and patient safety and is part of the project of attention to patients oncohematological and other specialties, which aims to achieve the highest standards of security.